EP3441069
TREATMENT OF DIABETIC RETINOPATHY USING PHARMACEUTICAL AGENTS THAT ELIMINATE SENESCENT CELLS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
13.8.2018EP published:
5.4.2023EP application number:
18188799.3
EPO information:
European Patent Register
Max expiry date:
12.8.2038
Title in English:
TREATMENT OF DIABETIC RETINOPATHY USING PHARMACEUTICAL AGENTS THAT ELIMINATE SENESCENT CELLSLanguage of the patent:
English
Timeline
Today
13.8.2018EP application
5.4.2023EP Publication
Owner
Name:
Unity Biotechnology, Inc.Address:
285 East Grand Avenue, South San Francisco, CA 94080, US
Inventor
Name:
Hopkins, JillAddress:
South San Francisco, CA 94080, US
Name:
Tsuruda, PamAddress:
South San Francisco, CA 94080, US
Name:
Chapman, ClaudeAddress:
South San Francisco, CA 94080, US
Name:
Sweigard, HarryAddress:
South San Francisco, CA 94080, US
Name:
Poon, YanAddress:
South San Francisco, CA 94080, US
Name:
Marquess, DanielAddress:
South San Francisco, CA 94080, US
Name:
David, NathanielAddress:
South San Francisco, CA 94080, US
Name:
Dananberg, JamieAddress:
South San Francisco, CA 94080, US
Name:
Laberge, Remi-MartinAddress:
South San Francisco, CA 94080, US
Priority
Number:
201715675171Date:
11.8.2017Country:
US
Number:
201762579793 PDate:
31.10.2017Country:
US
Classification
Categories:
A61K 31/496, A61K 31/675, A61P 27/02, A61P 27/06